40 A survival benefit of Tarceva was also observed in patients who did not achieve an objective tumour response (by RECIST).
40 Tarceva elulemust pikendavat toimet täheldati ka patsientidel, kes ei saavutanud objektiivset kasvaja ravivastust (RECIST’ i järgi).